Why AbCellera Biologics Stock Was Up More Than 17% on Friday – Motley Fool
What happened
Shares of biotechnology outfit AbCellera Biologics(NASDAQ:ABCL) were up 17.2% as of mid-session Friday following encouraging commentary within its second-quarter report.
So what
It certainly could have been worse.
For the three-month span…
